Legal News

EMA evaluates use of Comirnaty coronavirus (COVID-19) vaccine in 12–15-year olds

Published on: 09 February 2022
Published by LNB News

LNB News 09/02/2022

Document Information

Issue Date: 09 February 2022

Published Date: 09 February 2022

Jurisdiction(s): European Union

Article summary

The European Medicines Agency (EMA) has confirmed that it is evaluating an application to use a booster dose of the Comirnaty coronavirus (COVID-19) vaccine in children aged 12–15. The Committee for Medicinal Products for Human Use will be carrying out an accelerated assessment of data submitted by the company that markets the vaccine alongside real life evidence from Israel and EMA will communicate the outcome of the assessment ‘in due course’.

Popular documents